Good and bad memories following rituximab therapy.
St Clair
E William
EW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology*; D016175:B-Lymphocyte Subsets / Q000276:immunology; D006433:Hemocyanins / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects*; D007156:Immunologic Memory / Q000187:drug effects* / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage; D008212:Lymphocyte Depletion; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D000069283:Rituximab; D013745:Tetanus Toxoid / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D018501:Antirheumatic Agents; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D013745:Tetanus Toxoid; D000069283:Rituximab; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin